In summary, these data demonstrate that AXL/MERTK inhibition with INCB081776 hinders tumor growth by two distinct mechanisms—reversal of immunosuppression and ablation of intrinsic tumor cell survival signaling. This evidence concerns the gene AXL and neoplasm.